Loading...
In Vitro Skin Retention of Crisaborole after Topical Application
Crisaborole, a nonsteroidal phosphodiesterase 4 inhibitor, represents the first nonsteroidal medication approved for the treatment of atopic dermatitis in over a decade. In this work, crisaborole skin permeation and retention was studied in vitro from a 2% ointment using porcine skin as barrier. Cri...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7355453/ https://ncbi.nlm.nih.gov/pubmed/32481663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060491 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|